Literature DB >> 9642651

Persistent hyperinsulinemic hypoglycemia of infancy: long-term results.

C Dacou-Voutetakis1, F Psychou, M Maniati-Christidis.   

Abstract

Data from 15 infants with persistent hyperinsulinemic hypoglycemia of infancy (PHHI), presented to our hospital from 1976 to 1995, were retrospectively analyzed. Nine patients were successfully managed with prolonged (1.25-13 yr) diazoxide therapy and frequent, low protein feeds. Three of them are still being treated with diazoxide, 7.75, 9.25 and 13 yr post diagnosis. Four patients were managed only with frequent, low protein feeds. One patient had 2/3 pancreatectomy, and another had excision of a focal lesion which proved to be focal nesidioblastosis. Two patients were lost to follow up. No patient has shown neurological damage. One girl developed seizures at age 11.5 yr without hypoglycemia. The patient with 2/3 pancreatectomy developed diabetes mellitus at the age of 20 years. Although conservative management of PHHI is very laborious for the family and the physician, it should be applied as long as euglycemia is accomplished. Definition of the anatomical lesion (focal or diffuse) prior to pancreatectomy is recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642651     DOI: 10.1515/jpem.1998.11.s1.131

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  5 in total

1.  Congenital hyperinsulinism and glucose hypersensitivity in homozygous and heterozygous carriers of Kir6.2 (KCNJ11) mutation V290M mutation: K(ATP) channel inactivation mechanism and clinical management.

Authors:  Karen J Loechner; Alejandro Akrouh; Harley T Kurata; Carlo Dionisi-Vici; Arianna Maiorana; Milena Pizzoferro; Vittoria Rufini; Jean de Ville de Goyet; Carlo Colombo; Fabrizio Barbetti; Joseph C Koster; Colin G Nichols
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

2.  Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study.

Authors:  Annett Helleskov; Maria Melikyan; Evgenia Globa; Inna Shcherderkina; Fani Poertner; Anna-Maria Larsen; Karen Filipsen; Klaus Brusgaard; Charlotte Dahl Christiansen; Lars Kjaersgaard Hansen; Henrik T Christesen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-10       Impact factor: 5.555

Review 3.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

4.  Hyperinsulinemic hypoglycemia in adolescents: case report and systematic review.

Authors:  M G Castillo-López; M F Fernandez; N Sforza; N C Barbás; F Pattin; G Mendez; F Ogresta; I Gondolesi; P Barros Schelotto; C Musso; G E Gondolesi
Journal:  Clin Diabetes Endocrinol       Date:  2022-03-15

5.  Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.

Authors:  Senthil Senniappan; Atefeh Sadeghizadeh; Sarah E Flanagan; Sian Ellard; Mahin Hashemipour; Majid Hosseinzadeh; Mansour Salehi; Khalid Hussain
Journal:  BMC Res Notes       Date:  2015-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.